This study reviewed retrospectively women with these P/LP variants in BRCA1/2 followed in a High-Risk Breast Clinic, including patients with breast cancer, with the aim to characterize this population and identify whether there are clinical, demographic, or family characteristics that could be determinant when choosing the preventive strategy. This evidence concerns the gene BRCA1 and breast carcinoma.